Dr Reddy’s Is Ready For Rituximab Registrations
Indian Firm Is Planning Filings For Rituxan Biosimilar In US And Europe
Dr Reddy’s is preparing for rituximab filings in the US, Europe and other regions after successfully clearing clinical trials for its DRL RI proposed biosimilar rival to Rituxan.
